- Report
- April 2019
- 125 Pages
Global
From €5686EUR$5,950USD£4,838GBP
- Report
- January 2019
- 15 Pages
Global
- Report
- August 2021
- 507 Pages
Global
From €4778EUR$5,000USD£4,066GBP
- Report
- November 2023
- 81 Pages
France
From €3345EUR$3,500USD£2,846GBP
- Report
- October 2020
- 215 Pages
Global
From €3044EUR$3,185USD£2,590GBP
€4348EUR$4,550USD£3,700GBP
- Report
- March 2023
- 254 Pages
Global
From €3044EUR$3,185USD£2,590GBP
€4348EUR$4,550USD£3,700GBP
- Report
- October 2019
- 108 Pages
Asia Pacific
From €2007EUR$2,100USD£1,708GBP
€2867EUR$3,000USD£2,439GBP
- Report
- October 2019
- 111 Pages
Europe
From €2007EUR$2,100USD£1,708GBP
€2867EUR$3,000USD£2,439GBP
- Report
- October 2019
- 110 Pages
North America
From €2007EUR$2,100USD£1,708GBP
€2867EUR$3,000USD£2,439GBP
- Report
- June 2019
- 144 Pages
Global
From €3044EUR$3,185USD£2,590GBP
€4348EUR$4,550USD£3,700GBP
- Report
- November 2023
- 77 Pages
India
From €3345EUR$3,500USD£2,846GBP
- Report
- October 2023
- 78 Pages
India
From €3345EUR$3,500USD£2,846GBP
- Report
- October 2023
- 70 Pages
Egypt
From €3345EUR$3,500USD£2,846GBP
From €3345EUR$3,500USD£2,846GBP
- Report
- February 2023
- 79 Pages
Saudi Arabia
From €3345EUR$3,500USD£2,846GBP
- Report
- June 2020
- 112 Pages
Global
From €4539EUR$4,750USD£3,862GBP
- Report
- July 2022
- 100 Pages
Global
From €2628EUR$2,750USD£2,236GBP
- Report
- November 2022
- 100 Pages
Global
From €2628EUR$2,750USD£2,236GBP
- Report
- October 2022
- 100 Pages
Global
From €2628EUR$2,750USD£2,236GBP
- Report
- October 2022
- 100 Pages
Global
From €2628EUR$2,750USD£2,236GBP
Inhalers and nebulisers are medical devices used to deliver medication to the lungs. Inhalers are handheld devices that deliver medication in the form of a mist or aerosol, while nebulisers are larger machines that deliver medication in the form of a fine mist. Inhalers are the most common form of medication delivery for respiratory conditions such as asthma and COPD.
Inhalers and nebulisers are used by millions of people around the world, and the market for these devices is highly competitive. Companies in the market are constantly innovating to develop new and improved devices that are more effective and easier to use. Many of these devices are now available over the counter, making them more accessible to patients.
The inhaler market is also highly regulated, with governments and health authorities setting standards for the safety and efficacy of these devices. Companies must adhere to these standards in order to remain competitive.
Some of the major companies in the inhaler market include GlaxoSmithKline, Boehringer Ingelheim, AstraZeneca, Novartis, Merck, and Teva Pharmaceuticals. Show Less Read more